Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apialpharma
Madrid, Madrid, Spainapialpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Apial Pharma is a Spanish biotechnology company focused on the development of innovative pharmaceutical products, particularly in the field of cannabinoid-based therapies. The company leverages its expertise in drug delivery and formulation to create treatments for pain management, inflammation, and various neurological conditions. Apial Pharma aims to bridge the gap between traditional pharmacology and the therapeutic potential of cannabinoids through rigorous scientific research and clinical development. Their current efforts are centered on optimizing the bioavailability and safety profiles of their lead compounds to address unmet medical needs.
- Therapeutic areas
- ImmunologyNeurology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Apialpharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apialpharma.